Jardiance is an oral sodium-glucose co-transporter 2 (SGLT2) inhibitor indicated for improving glycemic control in type 2 diabetes and reducing cardiovascular death, hospitalization for heart failure, and progression of chronic kidney disease. It lowers blood glucose by promoting urinary glucose excretion and provides cardiorenal benefits through hemodynamic and metabolic effects. #diabetesawareness #diabetes #heartdisease #medicineexplained #kidneydisease

Kidney Disease Is Exploding — But Big Breakthroughs Just Dropped Kidney disease is rising fast, but the new science from Kidney Week 2025 changes everything. From SGLT2 inhibitors to GLP-1s to fish oil in dialysis, we finally have real tools to protect our communities. I’m NBHD Doc B, Board-Certified Family Medicine Doctor — here’s what you need to know to stay ahead of this silent crisis. Save this. Share this. Someone you love needs to hear it. #KidneyHealth #CKDAwareness #DiabetesPrevention #

Are SGLT2 Inhibitors Only For Type 2 Diabetes?

Diabetes in Cats: Choosing the Right Treatment & Monitoring | Insulin vs. SGLT2 Inhibitors

Immunoglobulin A (IgA) Nephropathy, Glomerulonephritis: Causes, Diagnosis, and Management, Nephrolog